Clinical Guidance Outlines Safe GLP-1RA Use, Titration, and Monitoring for Adults with Type 1 Diabetes
Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes.
Abstract
New clinical guidance details safe initiation, titration, and monitoring of GLP-1RAs as adjunctive therapy for adults with Type 1 Diabetes.